Effect of Indion Complexation on the Stability and Bioavailability of Some Non-steroidal Anti-inflammatory Drugs
Keywords:
Paracetamol, Ibuprofen, Ion exchange, Indion 204, BioavailabilityAbstract
Ion exchange resins are commonly used for masking of drug objectionable taste. Our work aimed to study the effect of this complexation on the drug stability and bioavailability in rabbits. In this work, paracetamol and ibuprofen complexes with indion 204 were prepared; drug stability and bioavailability from the prepared complexes were studied and compared with that of the commonly used commercial tablets Tylenol and Motrin respectively. The clinical protocol and information about drugs were discussed with a group of healthy albino rabbits. The results showed that tmax of both drugs were kept constant at 1.5hrs and 2hrs without any change from the reference standards Tylenol and Motrin respectively. The calculated pharmacokinetic parameters Cpmax, AUC(0-24) and AUC(0-∞) respectively for paracetamol were 0.431µg/ml, 3.535µg.hr/ml and 3.756µg.hr/ml from the prepared complexes in comparison to 0.494µg/ml, 4.083µg.hr/ml, 4.198µg.hr/ml from Tylenol, and 0.743µg/ml, 5.380µg.hr/ml, 5.559µg.hr/ml from the prepared ibuprofen complexes in comparison to 0.803µg/ml, 6.272 µg.hr/ml, 6.432 µg.hr/ml from Motrin. The relative bioavailability of both drugs from the prepared complexes were calculated using Tylenol and Motrin as reference standards and the 90 % confidence intervals of the geometric mean values for the test/reference ratios for Cpmax, AUC (0-24) and AUC (0-∞) were within the bioequivalence acceptance range of 80–125 % according to the European Guideline. Statistical analysis (ANOVA) indicated a significance difference between the calculated pharmacokinetic parameters for both drugs. From these results we can conclude that indion complexation of drugs significantly affects their pharmacokinetics and retards their bioavailability.
References
Mennella JA, Beauchamp GK. Optimizing Oral Medications for Children. Clin. Ther.2008; 30(11):2120-32.
Yajima T, Nogata A and Damachi M. Particle design for taste masking using spray congelling technique. Chem.Phrm.Bull. 1996; 44(1): 187-191.
Suthar AM and Patel MM. Ion exchange resin as an imposing method for taste masking: A review. Pharma Science Monitor. 2010; 1(2): 6-12.
Agarwal R, Mittal R and Singh A. Studies of Ion-Exchange Resin Complex of Chloroquine Phosphate. Drug Dev. Ind. Pharm. 2000; 6: 773-776.
Australian Prescriber. Paediatric analgesia. 2008; 31:63-5
Budavari S ed. The Merck Index: an encyclopedia of chemicals, drugs and biologicals, 12th ed. Rahway, New Jersey, Merck and Co., Inc.;1996.
Forrest JA, Clements JA and Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet. 1982;7(2):93-107.
"Ibuprofen". The American Society of Health-System Pharmacists. Retrieved 3 April 2011.
Neupert W, Brugger R, Euchenhofer C, Brune K and Geisslinger G. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br J Pharmacol. 1997; 122:487-492.
Rao P and Knaus EE. "Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): Cyclooxygenase (COX) inhibition and beyond". Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2008;11(2): 81–110.
Kakuta H, Zheng X, Oda H, Harada S, Sugimoto Y, Sasaki K and Tai A. Cyclooxygenase-1-Selective Inhibitors Are Attractive Candidates for Analgesics That Do Not Cause Gastric Damage. Design and in Vitro/in Vivo Evaluation of a Benzamide-Type Cyclooxygenase-1 Selective Inhibitor. Journal of Medicinal Chemistry. 2008; 51(8): 2400–2411.
Frölich JC and Fricker RM: [Pain therapy and analgetics-antipyretics (Nonsteroidal antirheumatic drugs – NSAR)]. In Praktische Arzneitherapie. 4th edition. Edited by Frölich JC, Kirch W. Heidelberg: Springer; 2006:675-706.
Pande SV, Kshirsagar MD and Chandewar AV. Ion exchange resins pharmaceutical applications and recent advancement. International Journal of Advances in Pharmaceutical Sciences. 2011; 2: 8-16.
Amr Helmy, Sherien El Kady, Ahmed Khames, Ahmed Abd-elbary. Preparation, Characterization, and In-vitro/vivo Evaluation of Indion-based Chewable Tablets of Paracetamol and Ibuprofen for Pediatric Use. Journal of American Science 2011;7(12):831-844.
Avari NG and Bhalekar M. Cation exchange resins for taste masking and rapid dissolution of sparfloxacin. Indian Drugs. 2004; 41(1): 19-23.
Note for guidance on the investigation of bioavailability and bioequivalence. The European agency for the evaluation of medicinal products (Evaluation of Medicines for Human Use). London: Committee for Proprietary Medicinal Products. 2001.
Padet GE and Barnes JM. Toxicity tests. In: Laurence, D. R. & Bacharach, A. L., ed. Evaluation of drug activities: Pharmacometrics, London, New York, Academic Press. 1964;1. p. 135-166.
Guideline on the Investigation of Bioequivalence (CPMP/EWP/ QWP/1401/98 Rev. 1/Corr, London 20 January 2010.
Esimonea CO, Okoyeb FBC, Onaha BU, Nworuc CS, and Omejeb EO. In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria. J Vector Borne Dis, 2008;45:60–65
